Boston Scientific will use the new license in ultra-low power integrated circuits for implantable cardiac rhythm management device applications.
Sean Redmond, vice president of worldwide field operations at ARC International, said: “Led by ARC and its low power microprocessor technology, the semiconductor industry is beginning to make a significant contribution to the medical device industry.
“We applaud Boston Scientific’s innovative application of our technology in improving healthcare in patients worldwide, and look forward to contributing to their continuing success.”